Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TT48MP6)

• DTT Name: Dystrophin (DMD) DTT Info
• Gene Name: DMD

Molecule-Related Drug & Molecule List

5 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Fordadistrogene movaparvovec	DMZ3X7F	Duchenne muscular dystrophy	8C70.1	Phase 3	[1]
WVE-210201	DMHXJ68	Duchenne dystrophy	8C70	Phase 2/3	[2]
SRP-9001	DMR09IH	Duchenne dystrophy	8C70	Phase 2	[3]
Biostrophin	DMS4P6K	Duchenne dystrophy	8C70	Phase 1	[4]
MyoDys	DMHO6XP	Duchenne dystrophy	8C70	Phase 1	[5]

References

• [1] ClinicalTrials.gov (NCT05689164) Long-term Follow-up Safety and Efficacy Study in Participants With Duchenne Muscular Dystrophy Who Have Received Fordadistrogene Movaparvovec in a Preceding Clinical Study. U.S.National Institutes of Health.
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [3] Clinical pipeline report, company report or official report of Sarepta Therapeutics.
• [4] Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches. Nat Rev Genet. 2013 Jun;14(6):373-8.
• [5] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009280)